mail
editor@ajptr.com
whatsapp
9409046853
logo

American Journal of PharmTech Research

Published

Immunostimulant- Adjuvant Therapy For Influenza A (H1N1)

Published in February 2018 Issue 1 (Vol. 8, Issue 1, 2018)

Immunostimulant- Adjuvant Therapy For Influenza A (H1N1) - Issue cover

Abstract

Swine flu is an acute respiratory disease of pigs caused by tiny spheroid virus that is H1N1 virus that belongs to the influenza A virus group. This virus spread the infection in to the people through sneezing, coughing, splitting, inhaling infected droplets. Oseltamivir is now drug of choice for the swine flu, but it has several side effects. The primary infection of H. influenza to the host stimulates the host immune system. Immunostimulant property of herbal drugs proved to stimulate T cell and macrophages that can be used as adjuvant therapy for Swine flu treatment to stimulate the low host immune system. This review is an attempt to discuss the role of immune-stimulant as adjuvant therapy for H1N1.

Authors (4)

Abhinandan A. Alman

View all publications →

Pallavi. S. Jadhav

View all publications →

Rajshekhar. M. Chimkode

View all publications →

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Article Information

Article ID:
AJPTR81027
Paper ID:
AJPTR-01-001594
Published Date:
2018-02-01

Article Impact

Views:3,040
Downloads:2,397
scite_
PlumX Metrics Badge

How to Cite

A., A., & S., P. & Aswale & M., R. (2018). Immunostimulant- Adjuvant Therapy For Influenza A (H1N1). American Journal of PharmTech Research, 8(1), xx-xx. DOI:https://doi.org/10.46624/ajptr.2018.v8.i1.027

Article Actions

Whatsapp